These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 22016811)
1. Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma. Bunt J; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M PLoS One; 2011; 6(10):e26058. PubMed ID: 22016811 [TBL] [Abstract][Full Text] [Related]
2. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma. Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066 [TBL] [Abstract][Full Text] [Related]
3. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines. Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732 [TBL] [Abstract][Full Text] [Related]
4. Modeling medulloblastoma in vivo and with human cerebellar organoids. Ballabio C; Anderle M; Gianesello M; Lago C; Miele E; Cardano M; Aiello G; Piazza S; Caron D; Gianno F; Ciolfi A; Pedace L; Mastronuzzi A; Tartaglia M; Locatelli F; Ferretti E; Giangaspero F; Tiberi L Nat Commun; 2020 Jan; 11(1):583. PubMed ID: 31996670 [TBL] [Abstract][Full Text] [Related]
5. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels. Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372 [TBL] [Abstract][Full Text] [Related]
6. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Bunt J; Hasselt NE; Zwijnenburg DA; Hamdi M; Koster J; Versteeg R; Kool M Int J Cancer; 2012 Jul; 131(2):E21-32. PubMed ID: 21964830 [TBL] [Abstract][Full Text] [Related]
7. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356 [TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma. Qin N; Paisana E; Picard D; Leprivier G; Langini M; Custódia C; Cascão R; Conrad C; Peitzsch M; Stefanski A; Stühler K; Fischer U; Faria CC; Dietrich S; Reifenberger G; Remke M J Neurooncol; 2023 Nov; 165(2):329-342. PubMed ID: 37976029 [TBL] [Abstract][Full Text] [Related]
9. A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing. Saulnier O; Zagozewski J; Liang L; Hendrikse LD; Layug P; Gordon V; Aldinger KA; Haldipur P; Borlase S; Coudière-Morrison L; Cai T; Martell E; Gonzales NM; Palidwor G; Porter CJ; Richard S; Sharif T; Millen KJ; Doble BW; Taylor MD; Werbowetski-Ogilvie TE Nat Cell Biol; 2024 Aug; 26(8):1233-1246. PubMed ID: 39025928 [TBL] [Abstract][Full Text] [Related]
11. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. Adamson DC; Shi Q; Wortham M; Northcott PA; Di C; Duncan CG; Li J; McLendon RE; Bigner DD; Taylor MD; Yan H Cancer Res; 2010 Jan; 70(1):181-91. PubMed ID: 20028867 [TBL] [Abstract][Full Text] [Related]
12. The Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma. Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567 [TBL] [Abstract][Full Text] [Related]
14. OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells. Kaur R; Aiken C; Morrison LC; Rao R; Del Bigio MR; Rampalli S; Werbowetski-Ogilvie T Dis Model Mech; 2015 Oct; 8(10):1295-309. PubMed ID: 26398939 [TBL] [Abstract][Full Text] [Related]
15. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma. Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797 [TBL] [Abstract][Full Text] [Related]
16. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137. Wang J; Sui Y; Li Q; Zhao Y; Dong X; Yang J; Liang Z; Han Y; Tang Y; Ma J Cell Death Dis; 2020 Dec; 11(12):1029. PubMed ID: 33268769 [TBL] [Abstract][Full Text] [Related]
17. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208 [TBL] [Abstract][Full Text] [Related]
18. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways. Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460 [TBL] [Abstract][Full Text] [Related]
19. OTX1 and OTX2 Genes in Medulloblastoma. Figueira Muoio VM; Uno M; Oba-Shinjo S; da Silva R; Araújo Pereira BJ; Clara C; Matushita H; Marie SNK World Neurosurg; 2019 Jul; 127():e58-e64. PubMed ID: 30797919 [TBL] [Abstract][Full Text] [Related]
20. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Boon K; Eberhart CG; Riggins GJ Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]